CHCR — Advanzeon Solutions Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $10.55m
- $0.30m
Annual income statement for Advanzeon Solutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.438 | 0.21 | 0.564 | 0.524 | 0.3 |
Cost of Revenue | |||||
Gross Profit | 0.428 | 0.163 | 0.278 | 0.263 | 0.155 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.63 | 3.28 | 5.01 | -5.74 | 2.13 |
Operating Profit | -2.19 | -3.07 | -4.45 | 6.26 | -1.83 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.56 | -4.54 | -5.89 | 4.83 | -3.26 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.56 | -4.54 | -5.89 | 4.83 | -3.26 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.56 | -4.54 | -5.89 | 4.83 | -3.26 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.56 | -4.54 | -5.89 | 4.83 | -3.26 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.069 | -0.077 | -0.093 | -0.045 | -0.049 |